Biosimilars: Should We Embrace the new Biotechnology Medicines? :@0.294552:0.048195:0.905174:0.048195:0.905174:0.030552:0.294552:0.030552:0.010658:0.003713:0.012162:0.007204:0.003713:0.017416:0.003713:0.003713:0.012681:0.005589:0.007204:0.005143:0.005143:0.009246:0.011326:0.012162:0.011289:0.003713:0.012719:0.005143:0.017825:0.012069:0.005143:0.009952:0.017416:0.012663:0.005589:0.012681:0.012013:0.012069:0.005143:0.006294:0.011326:0.012069:0.005143:0.013740:0.012069:0.015429:0.005143:0.010658:0.003713:0.012162:0.006294:0.012069:0.012013:0.011326:0.011326:0.012162:0.003713:0.012162:0.012496:0.009952:0.005143:0.017063:0.012069:0.012719:0.003713:0.012013:0.003713:0.011326:0.012069:0.007204:0.010973:0.005143
39:@0.939541:0.050820:0.959874:0.050820:0.959874:0.028278:0.939541:0.028278:0.010167:0.010167
response. This, however, does not immedi-:@0.099415:0.107138:0.476609:0.107138:0.476609:0.089495:0.099415:0.089495:0.005589:0.012069:0.007204:0.012663:0.012162:0.011326:0.007204:0.012069:0.005143:0.005050:0.007910:0.011326:0.003713:0.007204:0.005143:0.005050:0.011326:0.012162:0.015429:0.012069:0.010286:0.012069:0.005589:0.005143:0.005050:0.012719:0.012162:0.012069:0.007204:0.005050:0.011326:0.012162:0.006294:0.005050:0.003713:0.017416:0.017416:0.012069:0.012719:0.003713:0.006164
ately address the needs of the poor who :@0.099415:0.122949:0.481790:0.122949:0.481790:0.105306:0.099415:0.105306:0.012811:0.006424:0.012199:0.003843:0.010082:0.006294:0.012811:0.012849:0.012849:0.005719:0.012199:0.007334:0.007334:0.006294:0.006424:0.011456:0.012199:0.006294:0.011456:0.012199:0.012199:0.012849:0.007334:0.006294:0.012292:0.005960:0.006294:0.006424:0.011456:0.012199:0.006294:0.012793:0.012292:0.012292:0.005719:0.006294:0.015559:0.011456:0.012162:0.005143
will, despite the efforts of making biosimi-:@0.099415:0.138772:0.476702:0.138772:0.476702:0.121129:0.099415:0.121129:0.015559:0.003843:0.003843:0.003843:0.005273:0.006294:0.012849:0.012199:0.007334:0.012793:0.003843:0.006424:0.012199:0.006294:0.006424:0.011437:0.012199:0.006294:0.012199:0.005960:0.005960:0.012292:0.005700:0.006406:0.007334:0.006294:0.012273:0.005960:0.006294:0.017546:0.012811:0.009451:0.003843:0.011456:0.012626:0.006294:0.012793:0.003843:0.012273:0.007334:0.003843:0.017546:0.003843:0.006164
lars or coming up with ingenious access :@0.099415:0.154583:0.481623:0.154583:0.481623:0.136939:0.099415:0.136939:0.004103:0.013071:0.005979:0.007594:0.006554:0.012551:0.005979:0.006554:0.012403:0.012551:0.017806:0.004103:0.011716:0.012886:0.006554:0.011679:0.013053:0.006554:0.015819:0.004103:0.006684:0.011716:0.006554:0.004103:0.011716:0.012886:0.012459:0.011716:0.004103:0.012551:0.011679:0.007594:0.006554:0.013071:0.012403:0.012403:0.012459:0.007594:0.007204:0.005143
programmes, still not be able to afford :@0.099415:0.170406:0.481623:0.170406:0.481623:0.152763:0.099415:0.152763:0.013350:0.006276:0.012849:0.013183:0.006276:0.013368:0.018103:0.018103:0.012756:0.007891:0.005830:0.006851:0.007891:0.006981:0.004400:0.004400:0.004400:0.006851:0.012013:0.012849:0.006981:0.006851:0.013350:0.012756:0.006851:0.013368:0.013350:0.004400:0.012756:0.006851:0.006981:0.012849:0.006851:0.013368:0.006517:0.006517:0.012849:0.006276:0.012719:0.005143
these new technologies. :@0.099415:0.186216:0.324321:0.186216:0.324321:0.168573:0.099415:0.168573:0.006294:0.011326:0.012069:0.007204:0.012069:0.005143:0.011326:0.012069:0.015429:0.005143:0.006294:0.012069:0.012013:0.011326:0.011326:0.012162:0.003713:0.012162:0.012496:0.003713:0.012069:0.007204:0.005143:0.005143
In conclusion, biosimilars will reduce the :@0.116961:0.202040:0.481530:0.202040:0.481530:0.184397:0.116961:0.184397:0.004178:0.011307:0.006146:0.011994:0.012143:0.011307:0.011994:0.003695:0.011270:0.007186:0.003695:0.012143:0.011307:0.005125:0.006146:0.012644:0.003695:0.012143:0.007186:0.003695:0.017398:0.003695:0.003695:0.012663:0.005570:0.007186:0.006146:0.015411:0.003695:0.003695:0.003695:0.006146:0.005570:0.012050:0.012700:0.011270:0.011994:0.012050:0.006146:0.006276:0.011307:0.012069:0.005143
price of biological medicines. However, :@0.099415:0.217863:0.481715:0.217863:0.481715:0.200220:0.099415:0.200220:0.013108:0.006016:0.004159:0.012459:0.012496:0.006610:0.012589:0.006257:0.006610:0.013108:0.004159:0.012589:0.004159:0.012589:0.012923:0.004159:0.012440:0.013127:0.004159:0.006610:0.017862:0.012496:0.013164:0.004159:0.012440:0.004159:0.011753:0.012496:0.007650:0.005570:0.006610:0.013127:0.012589:0.015875:0.012496:0.010732:0.012496:0.006016:0.005143:0.005143
access will remain restricted in the near :@0.099415:0.233674:0.481864:0.233674:0.481864:0.216030:0.099415:0.216030:0.013127:0.012459:0.012459:0.012514:0.007650:0.007650:0.006610:0.015875:0.004159:0.004159:0.004159:0.006610:0.006034:0.012514:0.017862:0.013127:0.004159:0.011772:0.006610:0.006034:0.012514:0.007650:0.006740:0.006034:0.004159:0.012459:0.006740:0.012514:0.013164:0.006610:0.004159:0.011772:0.006610:0.006740:0.011772:0.012514:0.006610:0.011772:0.012514:0.013127:0.005589:0.005143
future due to the cost of development and :@0.099415:0.249484:0.481771:0.249484:0.481771:0.231841:0.099415:0.231841:0.005644:0.011103:0.006109:0.011103:0.005403:0.011883:0.004512:0.012533:0.011103:0.011883:0.004512:0.006109:0.011976:0.004512:0.006109:0.011140:0.011883:0.004512:0.011827:0.011976:0.007018:0.006109:0.004512:0.011976:0.005644:0.004512:0.012533:0.011883:0.010101:0.011883:0.003528:0.011976:0.012477:0.017230:0.011883:0.011140:0.006109:0.004512:0.012496:0.011140:0.012719:0.005143
future pharmacovigilance programmes. :@0.099415:0.265307:0.481864:0.265307:0.481864:0.247664:0.099415:0.247664:0.006220:0.011679:0.006684:0.011679:0.005979:0.012459:0.006554:0.013053:0.011716:0.013071:0.005979:0.017806:0.013071:0.012403:0.012551:0.010676:0.004103:0.012886:0.004103:0.004103:0.013071:0.011716:0.012403:0.012459:0.006554:0.013053:0.005979:0.012551:0.012886:0.005979:0.013071:0.017806:0.017806:0.012459:0.007594:0.005143:0.005143
only when more players enter the market :@0.523399:0.107138:0.905606:0.107138:0.905606:0.089495:0.523399:0.089495:0.016061:0.011252:0.003639:0.009878:0.006109:0.015355:0.011252:0.011994:0.011252:0.006109:0.017342:0.012087:0.005514:0.011994:0.006109:0.012589:0.003639:0.012607:0.009878:0.011994:0.005514:0.007130:0.006109:0.011994:0.011252:0.006220:0.011994:0.005514:0.006109:0.006220:0.011252:0.011994:0.006109:0.017342:0.012607:0.005514:0.009246:0.011994:0.006294:0.005143
and regulatory authorities come to under-:@0.523399:0.122949:0.900444:0.122949:0.900444:0.105306:0.523399:0.105306:0.012533:0.011177:0.012570:0.006016:0.005440:0.011920:0.012347:0.011140:0.003565:0.012533:0.006146:0.012013:0.005440:0.009804:0.006016:0.012533:0.011140:0.006146:0.011177:0.012013:0.005440:0.003565:0.006146:0.003565:0.011920:0.007056:0.006016:0.011864:0.012013:0.017268:0.011920:0.006016:0.006146:0.012013:0.006016:0.011140:0.011177:0.012570:0.011920:0.005440:0.006164
stand the challenges of access and safety :@0.523399:0.138772:0.905773:0.138772:0.905773:0.121129:0.523399:0.121129:0.007018:0.006109:0.012496:0.011140:0.012533:0.005514:0.006109:0.011140:0.011883:0.005514:0.011827:0.011140:0.012496:0.003528:0.003528:0.011883:0.011140:0.012310:0.011883:0.007018:0.005514:0.011976:0.005644:0.005514:0.012496:0.011827:0.011827:0.011883:0.007018:0.007018:0.005514:0.012496:0.011140:0.012533:0.005514:0.007018:0.012496:0.005644:0.011883:0.006109:0.009952:0.005143
and the trade-offs inherent in these, will the :@0.523399:0.154583:0.905792:0.154583:0.905792:0.136939:0.523399:0.136939:0.012496:0.011140:0.012533:0.004605:0.006109:0.011140:0.011883:0.004605:0.006109:0.005403:0.012496:0.012533:0.011883:0.005979:0.011976:0.005644:0.005644:0.007018:0.004605:0.003528:0.011140:0.011140:0.011883:0.005403:0.011883:0.011140:0.006109:0.004605:0.003528:0.011140:0.004605:0.006109:0.011140:0.011883:0.007018:0.011883:0.004957:0.004605:0.015244:0.003528:0.003528:0.003528:0.004605:0.006109:0.011140:0.012069:0.005143
price of biosimilars come down signifi-:@0.523399:0.170406:0.900649:0.170406:0.900649:0.152763:0.523399:0.152763:0.013536:0.006461:0.004586:0.012886:0.012941:0.007037:0.013034:0.006703:0.007037:0.013536:0.004586:0.013034:0.008077:0.004586:0.018289:0.004586:0.004586:0.013554:0.006461:0.008077:0.007037:0.012886:0.013034:0.018289:0.012941:0.007037:0.013591:0.013034:0.016302:0.012199:0.007037:0.008077:0.004586:0.013368:0.012199:0.004586:0.006703:0.004586:0.006164
cantly. A country that currently has greater :@0.523399:0.186216:0.905773:0.186216:0.905773:0.168573:0.523399:0.168573:0.011827:0.012496:0.011140:0.006109:0.003528:0.009766:0.004957:0.004698:0.013554:0.004698:0.011827:0.011976:0.011103:0.011140:0.006109:0.005403:0.009766:0.004698:0.006109:0.011140:0.012496:0.006109:0.004698:0.011827:0.011103:0.005403:0.005403:0.011883:0.011140:0.006109:0.003528:0.009766:0.004698:0.011140:0.012496:0.007018:0.004698:0.012310:0.005403:0.011883:0.012496:0.006109:0.011883:0.005589:0.005143
access to biosimilars in Africa is kenya and :@0.523399:0.202040:0.905773:0.202040:0.905773:0.184397:0.523399:0.184397:0.012496:0.011827:0.011827:0.011883:0.007018:0.007018:0.005607:0.006109:0.011976:0.005607:0.012477:0.003528:0.011976:0.007018:0.003528:0.017230:0.003528:0.003528:0.012496:0.005403:0.007018:0.005607:0.003528:0.011140:0.005607:0.013554:0.005644:0.005403:0.003528:0.011827:0.012496:0.005607:0.003528:0.007018:0.005607:0.010788:0.011883:0.011140:0.009766:0.012496:0.005607:0.012496:0.011140:0.012719:0.005143
should perhaps be looked at for a model to :@0.523399:0.217863:0.905755:0.217863:0.905755:0.200220:0.523399:0.200220:0.007018:0.011140:0.011976:0.011103:0.003528:0.012533:0.004011:0.012477:0.011883:0.005403:0.011140:0.012496:0.012477:0.007018:0.004011:0.012477:0.011883:0.004011:0.003528:0.011976:0.011976:0.009135:0.011883:0.012533:0.004011:0.012496:0.006109:0.004011:0.005644:0.011976:0.005403:0.004011:0.012496:0.004011:0.017230:0.011976:0.012533:0.011883:0.003528:0.004011:0.006109:0.012162:0.005143
implement locally.:@0.523399:0.233674:0.685157:0.233674:0.685157:0.216030:0.523399:0.216030:0.003528:0.017230:0.012477:0.003528:0.011883:0.017230:0.011883:0.011140:0.006109:0.004957:0.003528:0.011976:0.011827:0.012496:0.003528:0.003528:0.009766:0.005143
References available on request.:@0.523399:0.265307:0.819361:0.265307:0.819361:0.246864:0.523399:0.246864:0.010769:0.011883:0.005199:0.011883:0.005942:0.011883:0.011140:0.011883:0.011883:0.008170:0.005199:0.012254:0.010398:0.012254:0.004456:0.004456:0.012254:0.012254:0.004456:0.011883:0.005199:0.011883:0.011140:0.005199:0.005942:0.011883:0.012254:0.011140:0.011883:0.008170:0.005570:0.005199